| 1A7X | A:; B: | FKBP12-FK1012 COMPLEX |
| 1B6C | A:; C:; E:; G: | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 |
| 1BKF | A: | FK506 BINDING PROTEIN FKBP MUTANT R42K/H87V COMPLEX WITH IMMUNOSUPPRESSANT FK506 |
| 1BL4 | A:; B: | FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND |
| 1D6O | A:; B: | NATIVE FKBP |
| 1D7H | A:; B: | FKBP COMPLEXED WITH DMSO |
| 1D7I | A:; B: | FKBP COMPLEXED WITH METHYL METHYLSULFINYLMETHYL SULFIDE (DSS) |
| 1D7J | A:; B: | FKBP COMPLEXED WITH 4-HYDROXY-2-BUTANONE |
| 1EYM | A:; B: | FK506 BINDING PROTEIN MUTANT, HOMODIMERIC COMPLEX |
| 1F40 | A: | SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH GPI-1046, A NEUROTROPHIC LIGAND |
| 1FAP | A: | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP |
| 1FKB | A: | ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP-12 COMPLEX |
| 1FKD | A: | FK-506 BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818 |
| 1FKF | A: | ATOMIC STRUCTURE OF FKBP-FK506, AN IMMUNOPHILIN-IMMUNOSUPPRESSANT COMPLEX |
| 1FKG | A: | DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 |
| 1FKH | A: | DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 |
| 1FKI | A:; B: | DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 |
| 1FKJ | A: | ATOMIC STRUCTURE OF FKBP12-FK506, AN IMMUNOPHILIN IMMUNOSUPPRESSANT COMPLEX |
| 1FKR | A: | SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN |
| 1FKS | A: | SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN |
| 1FKT | A: | SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN |
| 1J4H | A: | CRYSTAL STRUCTURE ANALYSIS OF THE FKBP12 COMPLEXED WITH 000107 SMALL MOLECULE |
| 1J4I | A: | CRYSTAL STRUCTURE ANALYSIS OF THE FKBP12 COMPLEXED WITH 000308 SMALL MOLECULE |
| 1J4R | A:; B:; D: | FK506 BINDING PROTEIN COMPLEXED WITH FKB-001 |
| 1NSG | A: | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP |
| 1QPF | A:; D: | FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-709,858 |
| 1QPL | A:; C: | FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-707,587 |
| 2DG3 | A: | WILDTYPE FK506-BINDING PROTEIN COMPLEXED WITH RAPAMYCIN |
| 2DG4 | A: | FK506-BINDING PROTEIN MUTANT WF59 COMPLEXED WITH RAPAMYCIN |
| 2DG9 | A: | FK506-BINDING PROTEIN MUTANT WL59 COMPLEXED WITH RAPAMYCIN |
| 2FAP | A: | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-(C16)-ETHOXY RAPAMYCIN COMPLEX INTERACTING WITH HUMA |
| 2FKE | A: | FK-506-BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818 |
| 2PPN | A: | CRYSTAL STRUCTURE OF FKBP12 |
| 2PPO | A: | CRYSTAL STRUCTURE OF E60A MUTANT OF FKBP12 |
| 2PPP | A: | CRYSTAL STRUCTURE OF E60Q MUTANT OF FKBP12 |
| 3FAP | A: | ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
| 3H9R | B: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN |
| 3MDY | B:; D: | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN-193189 |
| 4DH0 | A: | X-RAY CRYSTAL STRUCTURE OF 28-O-METHYLRAPAMYCIN COMPLEXED WITH FKBP12: IS THE CYCLOHEXYL MOIETY PART OF THE EFFECTOR DOMAIN OF RAPAMYCIN? |
| 4FAP | A: | ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
| 4IPX | A: | ANALYZING THE VISIBLE CONFORMATIONAL SUBSTATES OF THE FK506 BINDING PROTEIN FKBP12 |
| 4N19 | A: | STRUCTURAL BASIS OF CONFORMATIONAL TRANSITIONS IN THE ACTIVE SITE AND 80 S LOOP IN THE FK506 BINDING PROTEIN FKBP12 |
)
)